A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure
Michael Lichtenauer(Medical University of Vienna), Rudin Pistulli(Friedrich Schiller University Jena), Daniel Kretzschmar(Friedrich Schiller University Jena), Christian Jung(Heinrich Heine University Düsseldorf), Peter Jirak(Paracelsus Medical University), Atilla Yılmaz(Robert Bosch Hospital), Bernhard Wernly(Paracelsus Medical University), Lukas J. Motloch(Johannes Kepler University of Linz), Uta C. Hoppe(Baker Heart and Diabetes Institute), Christiana Schernthaner(Paracelsus Medical University), Ilonka Rohm(Friedrich Schiller University Jena), P. Christian Schulze(Columbia University Irving Medical Center), Johannes Kraus(University of Salzburg), Vera Paar(Paracelsus Medical University)
Cited by 65
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889